Showing results (191-200 of 534) with videos related to
Sort By:
Pageof 54
Cancer|September 1, 1976
Malignant histiocytosis: complete remission with combination chemotherapyR S Stein, E M Moran, G E ByrneInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 20, 2025
Controversies in vulvar cancer: revisiting the margin of errorMaureen E Byrne, Mario M Leitao, Nadeem R Abu-RustumJournal of the Neurological Sciences|March 1, 1991
Mitochondrial encephalomyopathies: a correlation between neuropathological findings and defects in mitochondrial DNAP A McKelvie, J B Morley, E Byrne, et al.The Journal of Biological Chemistry|December 10, 1984
Factors controlling the release from human blood polymorphonuclear cells in vitro of a proteolytic activity directed against apolipoprotein A-IID Polacek, R E Byrne, M Burrous, et al.The British Journal of Surgery|November 15, 2013
Population-based cohort study comparing 30- and 90-day institutional mortality rates after colorectal surgeryB E Byrne, R Mamidanna, C A Vincent, et al.BMJ Open|November 11, 2018
Evidence into practice: protocol for a new mixed-methods approach to explore the relationship between trials evidence and clinical practice through systematic identification and analysis of articles citing randomised controlled trialsBenjamin E Byrne, Leila Rooshenas, Helen Lambert, et al.Drug and Alcohol Review|September 1, 1996
Quantitative measure of muscle strength and size in chronic alcoholism: an early indication of tissue damageR Freilich, R Kirsner, G Whelan, et al.Frontiers in Plant Science|January 7, 2016
Dosage Sensitivity of RPL9 and Concerted Evolution of Ribosomal Protein Genes in PlantsDeborah Devis, Sue M Firth, Zhe Liang, et al.Life Sciences|August 30, 2022
Dopamine receptor 3: A mystery at the heart of cardiac fibrosisShannon E Byrne, Nandini Vishwakarma, Srinivas Sriramula, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 20, 2024
Evaluation of Dose-Response Relationship in Novel Extended Release of Targeted Nucleic Acid Nanocarriers to Treat Secondary CataractsCamila Vardar, Mindy George-Weinstein, Robert Getts, et al.Pageof 54